Latest Breaking News On - Prespecified analyses - Page 1 : comparemela.com

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial | Chronic Obstructive Pulmonary Disease | JAMA

This study examines whether the addition of bisoprolol to treatment of people with chronic obstructive pulmonary disease (COPD) at high risk of

United statesCity ofUnited kingdomSan diegoParticipantsthe bisoprololSanofi genzymeGraham devereuxAmerican thoracic society european respiratoryManchester biomedical research centreHealth services research unitScotlanda research ethics committeePragmatic research institute singaporeCare researchLothian respiratory managed clinical networkHull airway reflux questionnaireCentre for healthcare randomized trials

Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis

A prespecified analysis of the CLEAR Outcomes trial assessing outcomes according to glycemic status suggests bempedoic acid provided similar relative benefits across the glycemic spectrum, but the greatest absolute benefits were observed in patients with diabetes.

City ofUnited kingdomNoord hollandKausik rayCampbellp bempedoicSheldon koenigAmerican college of cardiologyEsperion therapeutics incInstitute kausik rayEuropean society of cardiologyImperial college londonEuropean society of cardiology congressEuropean societyImperial collegeAmerican collegeNew onset diabetes

Daiichi Sankyo Europe: New secondary analysis of CLEAR Outcomes data for bempedoic acid show significant risk reduction of total cardiovascular events and no increase of new-onset diabetes in patients at high-risk of cardiovascular disease

Daiichi Sankyo Europe: New secondary analysis of CLEAR Outcomes data for bempedoic acid show significant risk reduction of total cardiovascular events and no increase of new-onset diabetes in patients at high-risk of cardiovascular disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomDaiichi sankyoStefan seyfriedDaiichi sankyo europe gmbDaiichi sankyo europeKausik rayWolfgang schiesslEuropean medicines agencyProfessor of public healthEuropean society of cardiologyEuropean atherosclerosis societySankyo europeCholesterol loweringBempedoic acidInhibiting regimen

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at European Society of Cardiology

– In total cardiovascular event analysis, bempedoic acid shows20% risk reductionin MACE-4 and 17% risk reduction in MACE-3–

Noord hollandTiffany aldrichKausikk rayStephen nichollsSheldon koenigAlexis callahanPhd victorian heart instituteFmedsci imperial college londonExchange commissionEuropean society of cardiologyMonash universityLate breaking science sessionEuropean societyVictorian heart instituteNew onset diabetesGlycaemic status

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at

– In total cardiovascular event analysis, bempedoic acid shows 20% risk reduction in MACE-4 and 17% risk reduction in MACE-3 – – In an analysis of.

Noord hollandAlexis callahanStephen nichollsTiffany aldrichSheldon koenigKausikk rayPhd victorian heart instituteExchange commissionFmedsci imperial college londonMonash universityEuropean society of cardiologyLate breaking science sessionEuropean societyVictorian heart instituteNew onset diabetesGlycaemic status